General Biologicals Balance Sheet Health
Financial Health criteria checks 1/6
General Biologicals has a total shareholder equity of NT$402.4M and total debt of NT$1.4B, which brings its debt-to-equity ratio to 344.3%. Its total assets and total liabilities are NT$3.2B and NT$2.8B respectively.
Key information
344.3%
Debt to equity ratio
NT$1.39b
Debt
| Interest coverage ratio | n/a |
| Cash | NT$216.67m |
| Equity | NT$402.42m |
| Total liabilities | NT$2.76b |
| Total assets | NT$3.16b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 4117's short term assets (NT$416.6M) exceed its short term liabilities (NT$407.5M).
Long Term Liabilities: 4117's short term assets (NT$416.6M) do not cover its long term liabilities (NT$2.4B).
Debt to Equity History and Analysis
Debt Level: 4117's net debt to equity ratio (290.5%) is considered high.
Reducing Debt: 4117's debt to equity ratio has increased from 78.3% to 344.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4117 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 4117 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 56.5% each year